SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-014837
Filing Date
2022-03-24
Accepted
2022-03-24 16:00:59
Documents
13
Period of Report
2022-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea157372-8k_inmunebio.htm   iXBRL 8-K 29698
2 FORM OF SECURITIES PURCHASE AGREEMENT ea157372ex10-1_inmunebio.htm EX-10.1 132064
  Complete submission text file 0001213900-22-014837.txt   372703

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20220322.xsd EX-101.SCH 3036
4 XBRL LABEL FILE inmb-20220322_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE inmb-20220322_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT ea157372-8k_inmunebio_htm.xml XML 3712
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 22766442
SIC: 2836 Biological Products, (No Diagnostic Substances)